Home
  >  
Section 14
  >  
Chapter 13,066

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin

Santos, R.P.; Sánchez, P.J.; Mejias, A.; Benjamin, D.K.; Walsh, T.J.; Patel, S.; Jafri, H.S.

Pediatric Infectious Disease Journal 26(4): 364-366

2007

ISSN/ISBN: 0891-3668
PMID: 17414408
DOI: 10.1097/01.inf.0000258698.98370.89
Accession: 013065321
Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

PDF emailed within 0-6 h: $19.90




Related References

Frankenbusch, K.; Eifinger, F.; Kribs, A.; Rengelshauseu, J.; Roth, B. 2006: Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight Journal of Perinatology: Official Journal of the California Perinatal Association 26(8): 511-514
Clemons, K.V.; Espiritu, M.; Parmar, R.; Stevens, D.A. 2005: Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis Antimicrobial Agents and ChemoTherapy 49(12): 4867-4875
Huang, S.S.; Chan, I.T.; Stone, R.M.; Baden, L.R. 2002: Successful treatment of angioinvasive aspergillosis during prolonged neutropenia with liposomal amphotericin, voriconazole, and caspofungin Infectious Diseases in Clinical Practice 11(6): 355-358
Lassaletta, A.; Perez, A.; Díaz, M.A.; Sevilla, J.; González-Vicent, M.; Madero, L. 2004: Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia Journal of Pediatric Hematology/Oncology 26(2): 117-119
Hamada, N.; Ishiga, M.; Tanaka, S.; Ooue, Y.; Itano, J.; Tanaka, H.; Yuzurio, S.; Horiuchi, T.; Suwaki, T.; Kimura, G.; Tanimoto, Y. 2021: Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis Internal Medicine 60(15): 2465-2468
Mpakosi, A.; Siopi, M.; Falaina, V.; Siafakas, N.; Roilides, E.; Kimouli, M.; Theodoraki, M.; Karle, P.; Meletiadis, J. 2016: Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin Medical Mycology Case Reports 12: 24-27
Kakeya, H.; Miyazaki, Y.; Senda, H.; Kobayashi, T.; Seki, M.; Izumikawa, K.; Yanagihara, K.; Yamamoto, Y.; Tashiro, T.; Kohno, S. 2008: Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 52(5): 1868-1870
Athanassiadou, F.; Tragiannidis, A.; Kourti, M.; Papageorgiou, T.; Velegraki, A.; Kalogera, A. 2005: Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia Pediatric Blood and Cancer 45(7): 1003-1004
Pagano, L.; Valentini, C.G.; Fianchi, L.; Caira, M. 2011: Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? Journal of ChemoTherapy 23(1): 5-8
Boots, R.J.; Paterson, D.L.; Allworth, A.M.; Faoagali, J.L. 1999: Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF Thorax 54(11): 1047-1049
Chandrasekar, P.H.; Cutright, J.L.; Manavathu, E.K. 2004: Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 10(10): 925-928
Ogawa, T.; Takezawa, K.; Tojima, I.; Shibayama, M.; Kouzaki, H.; Ishida, M.; Okabe, H.; Shimizu, T. 2012: Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin Auris Nasus Larynx 39(2): 224-228
Efe İris, N.; Güvenç, S.; Özçelik, T.ül.; Demirel, A.ıh.; Koçulu, S.; Çevik, E.; Arat, M. 2016: Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 33(4): 363-364
Saitoh, T.; Matsushima, T.; Shimizu, H.; Osaki, Y.; Yamane, A.; Irisawa, H.; Yokohama, A.; Uchiumi, H.; Handa, H.; Tsukamoto, N.; Karasawa, M.; Nojima, Y.; Murakami, H. 2008: Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B Japanese Journal of Clinical Hematology 49(2): 94-98
Graybill, J.R.; Bocanegra, R.; Gonzalez, G.M.; Najvar, L.K. 2003: Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin Journal of Antimicrobial ChemoTherapy 52(4): 656-662